May 12, 2015 | The Israeli creators of the universal flu vaccine, BiondVax Pharmaceuticals raised $10 million in its offering on Tuesday (today). The company issued its American Depository Shares (ADS) at $5.01 a piece. BiondVax was founded in 2003 and is headquartered in Nes Ziona.
Related posts
Israel Invests Millions To Help AI Comprehend Hebrew, Arabic
September 21, 2023
Cybersecurity Startup Cato Raises $238M With $3B Valuation
September 21, 2023
Israel, UK Ink Deal For Greater Innovation Collaboration
September 21, 2023
ALS Drug Receives Patent In Israel, Europe, Japan
September 20, 2023
Facebook comments